Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Jason Cole. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Jason Cole har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:BLUE / bluebird bio, Inc. | Chief Strategy & Financial Off | 189 546 |
US:ZLCS / | EVP,Corp Dev & General Counsel | 280 000 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Jason Cole. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Jason Cole som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-08-23 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −14 194 | 189 546 | −6,97 | 5,53 | −78 473 | 1 047 924 | |
2022-08-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −7 448 | 203 740 | −3,53 | 4,39 | −32 707 | 894 704 | |
2022-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
2022-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 25 000 | 211 188 | 13,43 | ||||
2022-01-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −3 387 | 186 188 | −1,79 | 9,64 | −32 659 | 1 795 336 | |
2022-01-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 584 | 189 575 | −0,83 | 9,40 | −14 893 | 1 782 422 | |
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −27 500 | 55 211 | −33,25 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −18 000 | 17 721 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −25 000 | 24 613 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −25 000 | 24 613 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −28 500 | 28 059 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −8 938 | 8 799 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −35 000 | 34 458 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 64 779 | 191 159 | 51,26 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 64 781 | 126 380 | 105,17 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 27 606 | 61 599 | 81,21 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 6 645 | 33 993 | 24,30 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 3 077 | 27 348 | 12,68 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 1 539 | 24 271 | 6,77 | ||||
2021-08-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 32 265 | 112 453 | 40,24 | ||||
2021-08-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 32 266 | 80 188 | 67,33 | ||||
2021-05-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 47 922 | −0,08 | 30,15 | −1 146 | 1 444 901 | |
2021-04-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −37 | 47 960 | −0,08 | 30,21 | −1 118 | 1 448 637 | |
2021-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 47 997 | −0,08 | 29,58 | −1 124 | 1 419 842 | |
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −665 | 48 035 | −1,37 | 28,16 | −18 727 | 1 352 728 | |
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 27 500 | 27 500 | |||||
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 2 165 | 48 700 | 4,65 | ||||
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 13 750 | 46 535 | 41,94 | ||||
2021-02-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 32 785 | −0,12 | 45,93 | −1 745 | 1 505 661 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −986 | 32 823 | −2,92 | 45,46 | −44 827 | 1 492 248 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 372 | 33 809 | −3,90 | 44,76 | −61 409 | 1 513 244 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −43 | 35 181 | −0,12 | 44,95 | −1 933 | 1 581 463 | |
2020-12-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 | 35 224 | 0,00 | 46,50 | −46 | 1 637 916 | |
2020-12-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −37 | 35 225 | −0,10 | 46,19 | −1 709 | 1 627 025 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −4 | 35 262 | −0,01 | 54,43 | −218 | 1 919 452 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −7 | 35 266 | −0,02 | 53,83 | −377 | 1 898 270 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −26 | 35 273 | −0,07 | 52,51 | −1 365 | 1 852 139 | |
2020-10-06 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 35 299 | −0,11 | 52,76 | −2 005 | 1 862 552 | |
2020-09-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −36 | 35 337 | −0,10 | 58,60 | −2 110 | 2 070 812 | |
2020-08-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −9 | 35 373 | −0,03 | 60,98 | −549 | 2 157 084 | |
2020-08-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −28 | 35 382 | −0,08 | 60,32 | −1 689 | 2 134 179 | |
2020-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 35 410 | −0,11 | 61,57 | −2 340 | 2 180 293 | |
2020-06-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −29 | 35 448 | −0,08 | 64,24 | −1 863 | 2 277 293 | |
2020-06-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −9 | 35 477 | −0,03 | 63,36 | −570 | 2 247 915 | |
2020-05-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 437 | 35 486 | 4,22 | ||||
2020-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 18 000 | 18 000 | |||||
2020-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 9 000 | 34 049 | 35,93 | ||||
2020-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 957 | 25 049 | −7,25 | 89,97 | −176 074 | 2 253 689 | |
2019-05-14 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −562 | 8 938 | −5,92 | ||||
2019-05-14 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 562 | 27 006 | 2,13 | 50,51 | 28 387 | 1 364 073 | |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 000 | 9 500 | −29,63 | ||||
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 248 | 0 | −100,00 | ||||
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −525 | 26 444 | −1,95 | 151,41 | −79 491 | 4 003 936 |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 723 | 26 969 | −17,51 | 150,13 | −859 207 | 4 048 918 |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 000 | 32 692 | 13,94 | 50,51 | 202 040 | 1 651 273 | |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 248 | 28 692 | 8,50 | 22,53 | 50 647 | 646 431 | |
2019-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2019-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 6 250 | 26 444 | 30,95 | ||||
2019-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −488 | 20 194 | −2,36 | 114,31 | −55 781 | 2 308 295 | |
2019-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −928 | 20 682 | −4,29 | 113,29 | −105 133 | 2 343 053 | |
2018-08-10 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 438 | 2 248 | −66,38 | ||||
2018-08-10 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 438 | 21 610 | 25,84 | 22,53 | 99 988 | 486 873 | |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −326 | 17 172 | −1,86 | 172,66 | −56 289 | 2 964 998 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −940 | 17 498 | −5,10 | 171,60 | −161 306 | 3 002 695 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −970 | 18 438 | −5,00 | 170,68 | −165 556 | 3 146 928 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 290 | 19 408 | −10,55 | 169,64 | −388 484 | 3 292 447 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −600 | 21 698 | −2,69 | 168,47 | −101 080 | 3 655 390 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −460 | 22 298 | −2,02 | 172,39 | −79 301 | 3 844 030 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 890 | 22 758 | −7,67 | 171,24 | −323 653 | 3 897 194 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −900 | 24 648 | −3,52 | 170,48 | −153 435 | 4 202 072 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −400 | 25 548 | −1,54 | 169,19 | −67 675 | 4 322 402 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −100 | 25 948 | −0,38 | 167,85 | −16 785 | 4 355 320 |
2018-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2018-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 6 250 | 26 048 | 31,57 | ||||
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −25 000 | 6 686 | −78,90 | ||||
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −118 | 19 798 | −0,59 | 203,60 | −24 025 | 4 030 873 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −296 | 19 916 | −1,46 | 202,68 | −59 993 | 4 036 573 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 113 | 20 212 | −5,22 | 201,57 | −224 352 | 4 074 214 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 062 | 21 325 | −4,74 | 200,88 | −213 336 | 4 283 804 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 003 | 22 387 | −4,29 | 199,43 | −200 031 | 4 464 693 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −710 | 23 390 | −2,95 | 198,46 | −140 908 | 4 642 026 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 027 | 24 100 | −7,76 | 197,61 | −400 548 | 4 762 309 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 458 | 26 127 | −8,60 | 196,63 | −483 325 | 5 137 446 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 951 | 28 585 | −9,36 | 195,57 | −577 116 | 5 590 266 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −6 743 | 31 536 | −17,62 | 194,65 | −1 312 543 | 6 138 568 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 359 | 38 279 | −12,28 | 193,74 | −1 038 275 | 7 416 330 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 160 | 43 638 | −2,59 | 192,49 | −223 290 | 8 399 944 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 25 000 | 44 798 | 126,28 | 22,53 | 563 250 | 1 009 299 | |
2018-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −147 | 19 798 | −0,74 | 174,17 | −25 603 | 3 448 273 | |
2018-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −982 | 19 945 | −4,69 | 173,26 | −170 138 | 3 455 603 | |
2017-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 126 | 31 686 | −13,92 | ||||
2017-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 126 | 20 927 | 32,44 | 22,53 | 115 489 | 471 485 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −435 | 13 500 | −3,12 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −435 | 15 801 | −2,68 | 100,05 | −43 522 | 1 580 890 |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 435 | 16 236 | 2,75 | 50,51 | 21 972 | 820 080 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −1 740 | 13 935 | −11,10 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −15 070 | 36 812 | −29,05 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Comon Stock |
S - Sale | X | −16 810 | 15 801 | −51,55 | 100,22 | −1 684 705 | 1 583 583 |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 1 740 | 32 611 | 5,64 | 50,51 | 87 887 | 1 647 182 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 15 070 | 30 871 | 95,37 | 22,53 | 339 527 | 695 524 | |
2017-04-28 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −3 750 | 51 882 | −6,74 | ||||
2017-04-28 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 3 750 | 15 801 | 31,12 | 22,53 | 84 488 | 355 997 | |
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 930 | 55 632 | −8,14 | ||||
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −4 930 | 12 051 | −29,03 | 100,07 | −493 366 | 1 205 995 |
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 930 | 16 981 | 40,91 | 22,53 | 111 073 | 382 582 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 225 | 15 675 | −25,00 | ||||
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 225 | 12 051 | −30,24 | 90,32 | −471 911 | 1 088 421 |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 225 | 17 276 | 43,36 | 50,51 | 263 915 | 872 611 | |
2017-02-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −666 | 12 051 | −5,24 | 80,22 | −53 429 | 966 775 |
2017-02-16 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −3 772 | 12 717 | −22,88 | 80,01 | −301 808 | 1 017 523 |
2017-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 28 500 | 28 500 | |||||
2017-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 7 100 | 16 489 | 75,62 | ||||
2017-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −549 | 9 389 | −5,52 | 67,10 | −36 838 | 630 002 | |
2016-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 20 900 | 20 900 | |||||
2016-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 5 500 | 9 938 | 123,93 | ||||
2015-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | 4 438 | 60 562 | 7,91 | ||||
2015-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 438 | 4 438 | 22,53 | 99 988 | 99 988 | ||
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 65 000 | −7,14 | ||||
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 88,30 | −44 152 | |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 500 | 500 | −83,33 | 87,54 | −218 856 | 43 771 |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 000 | 3 000 | −40,00 | 85,77 | −171 533 | 257 299 |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 5 000 | 22,53 | 112 650 | 112 650 | ||
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 70 000 | −2,78 | ||||
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 138,31 | −41 492 | |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 000 | 300 | −76,92 | 136,91 | −136 915 | 41 074 |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −700 | 1 300 | −35,00 | 135,30 | −94 713 | 175 895 |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 72 000 | −2,70 | ||||
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −119 | 0 | −100,00 | 152,86 | −18 191 | |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −168 | 119 | −58,54 | 151,71 | −25 487 | 18 053 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −220 | 287 | −43,39 | 150,28 | −33 062 | 43 131 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −258 | 507 | −33,73 | 148,75 | −38 378 | 75 418 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −402 | 765 | −34,45 | 147,89 | −59 453 | 113 139 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −833 | 1 167 | −41,65 | 146,83 | −122 311 | 171 352 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 74 000 | −6,33 | ||||
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 156,86 | −31 372 | |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 100 | 200 | −84,62 | 157,40 | −173 142 | 31 480 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −3 300 | 1 300 | −71,74 | 158,37 | −522 623 | 205 882 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −400 | 4 600 | −8,00 | 159,56 | −63 826 | 733 999 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 5 000 | 22,53 | 112 650 | 112 650 | ||
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 79 000 | −2,47 | ||||
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −672 | 0 | −100,00 | 184,62 | −124 065 | |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −381 | 672 | −36,18 | 185,53 | −70 686 | 124 674 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −368 | 1 053 | −25,90 | 186,60 | −68 667 | 196 485 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −447 | 1 421 | −23,93 | 187,72 | −83 911 | 266 751 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −132 | 1 868 | −6,60 | 188,24 | −24 847 | 351 626 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −9 000 | 81 000 | −10,00 | ||||
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 003 | 0 | −100,00 | 167,26 | −167 760 | |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 560 | 1 003 | −60,87 | 166,41 | −259 594 | 166 906 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −920 | 2 563 | −26,41 | 165,24 | −152 017 | 423 499 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 066 | 3 483 | −23,43 | 164,06 | −174 886 | 571 416 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 403 | 4 549 | −23,57 | 162,83 | −228 452 | 740 717 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 128 | 5 952 | −26,34 | 161,96 | −344 645 | 963 969 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −920 | 8 080 | −10,22 | 160,80 | −147 939 | 1 299 287 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 9 000 | 9 000 | 22,53 | 202 770 | 202 770 | ||
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 90 000 | −10,00 | ||||
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 114,58 | −11 458 | |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 617 | 100 | −94,18 | 113,42 | −183 395 | 11 342 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 809 | 1 717 | −51,30 | 112,41 | −203 357 | 193 015 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 994 | 3 526 | −36,12 | 111,47 | −222 263 | 393 028 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −4 480 | 5 520 | −44,80 | 110,42 | −494 693 | 609 533 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 10 000 | 10 000 | 22,53 | 225 300 | 225 300 | ||
2015-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
2014-04-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2014-03-12 | 3 | BLUE |
bluebird bio, Inc.
No securities are beneficially owned |
0 | ||||||||
2013-01-07 |
|
4 | ZLCS |
Zalicus Inc.
Stock Option (Right to Buy) |
A - Award | 280 000 | 280 000 | |||||
2012-01-31 |
|
4 | ZLCS |
Zalicus Inc.
Common Stock |
S - Sale | X | −2 420 | 15 086 | −13,82 | 1,09 | −2 638 | 16 444 |
2012-01-27 |
|
4 | ZLCS |
Zalicus Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 242 809 | 242 809 | |||||
2012-01-27 |
|
4 | ZLCS |
Zalicus Inc.
Incentive Stock Option (right to buy) |
A - Award | 107 191 | 107 191 | |||||
2006-01-25 | 3 | CRXX |
COMBINATORX, INC
No Securities Beneficially Owned |
0 |